TI

TradingView Ideaspage 33

Coverage, page 33

page 33 of 115

CoStar Group (CSGP): TA Review - Sellers Continue to push.

Good Afternoon, Hope all is well. Here is my TA on CSGP. What I’m Seeing Looking at CoStar Group on the weekly chart, the primary trend is still clearly bearish. Price has fallen from roughly $95–$100 to around $31, remains below a declining weekly trend/average, and has not yet established a confirmed higher-high/higher-low sequence. But I think the character of the decline is beginning to change. The first major breakdown came with a cluster of high-volume selling around $60–$70. That selling produced a substantial move lower. The next leg down toward roughly $40–$45 occurred on noticeably less volume. Then, as price reached the $27–$32 area, volume increased again—but instead of accelerating dramatically lower, price began consolidating. That's the relationship I'm interested in: heavy selling → large downside result → declining participation → final high-volume event → much less downside progress. To me, this could be transitioning from markdown toward seller exhaustion and potential accumulation. The Original High-Volume Cluster Looks Like Distribution The cluster you've marked around approximately $58–$68 looks important. Price was already below the declining weekly trend, several high-volume events appeared, and then support failed. In hindsight, I would interpret that area more as distribution / aggressive liquidation than accumulation. The key evidence is what happened afterward: price accepted materially lower levels. That's very different from what I'm beginning to see near $30. The Volume Progression Is Changing The next stage is particularly interesting. After the initial high-volume breakdown, CSGP continued declining—but volume decreased while price continued lower. That tells me the downtrend remained intact, but participation wasn't necessarily increasing with every new low. Then another high-volume event appeared around the low-$30s. This time, instead of immediately collapsing toward $20, price began moving sideways. That's potentially an effort-versus-result divergence: more selling effort + less bearish price progress. It doesn't prove institutional accumulation. But it tells me supply may be getting absorbed more effectively than it was earlier in the decline. $27–$32 Is My Decision Zone This is now the most important area on the chart for me. Price has spent several months around approximately $27–$32, and the lows have so far stopped extending materially downward. I'd describe this as a potential accumulation zone, rather than confirmed accumulation. What I want to see now is time. If CSGP continues trading around this region while volatility contracts, downside volume fades and momentum improves, the base becomes increasingly credible. The ideal next sequence would be: $27–$30 holds → higher low → $33–$35 reclaimed → expansion. Momentum Turning Positive Matters Your annotation that the daily momentum measure has turned positive for the first time since August 2025 is one of the more constructive signals on the chart. For most of this decline, price and momentum were confirming each other. Now price remains near the lows while momentum is improving. Combined with your observation that the negative directional component has moved beneath the broader directional/trend measure, I'd interpret your indicators as showing that bearish pressure is weakening. But there's an important distinction: sellers losing control ≠ buyers controlling the trend. I think we're potentially seeing the first part. I still need price to prove the second. $33–$35 Is My First Confirmation At approximately $31, CSGP is still inside the bottoming structure. My first meaningful confirmation would be a sustained move through approximately $33–$35. That would push price out of the immediate consolidation and remove a recent swing-high area. Then I want to see what happens on the pullback. My ideal structure would be: $27–$32 base → $35 breakout → controlled pullback → ~$30–$32 holds → higher low → continuation. That would look substantially different from every previous bounce during this decline. $40–$45 Is the Bigger Test Above the initial breakout, $40–$45 becomes much more important. That's where the previous breakdown accelerated and where trapped supply is likely to exist. It's also where the declining weekly trend/average is heading. So I'd roughly map the recovery as: $27–$32 → $33–$35 → $40–$45 → $50+ A reclaim of $40–$45 followed by a higher low would be much stronger evidence that I'm dealing with a genuine weekly reversal rather than simply an oversold bounce. Fundamentals — This Is Where CoStar Gets Interesting Fundamentally, CoStar doesn't look like a company whose core business is collapsing. In Q2 2026, revenue reached $925 million, up 18% year over year. Net income increased to $55 million from $6 million, while adjusted EBITDA rose 116% to $184 million. Adjusted EPS increased 88% to $0.32. Management also described Q2 as its 61st consecutive quarter of double-digit revenue growth. That's an important contrast with the chart: share price ↓ dramatically while revenue and adjusted profitability ↑. That doesn't automatically make the stock undervalued—valuation compression can happen even when a business grows—but it makes this potential technical bottom more interesting to me. Residential Is Starting to Improve One of the biggest questions around CoStar has been how much money it would need to invest in its residential strategy, particularly Homes.com. There are signs that economics are beginning to improve. In Q2, CoStar's residential revenue increased 33% year over year to $444 million, and the residential segment produced positive adjusted EBITDA for the quarter. Earlier this year, management also said it intended to reduce the net investment in Homes.com by more than $300 million in 2026, after roughly $850 million in 2025. That's important to my thesis. If CoStar can continue growing Homes.com while reducing the amount of capital required to support it, the market may begin looking differently at the residential business. But Growth Expectations Have Moderated There is still a legitimate reason for caution. After Q2, management revised full-year 2026 revenue guidance to approximately $3.715–$3.755 billion, or about 15% year-over-year growth at the midpoint. Earlier in 2026, the company had been targeting $3.78–$3.82 billion and roughly 18% growth. So I wouldn't describe everything as improving. The market may be repricing CoStar for a combination of slower-than-previously-expected growth and questions about returns on its large residential investments. The bullish counterargument is profitability: management maintained full-year adjusted EBITDA guidance of $780–$820 million, while Q2 adjusted EBITDA more than doubled year over year. That creates an interesting fundamental tension: growth expectations moderating + profitability improving. The Zonda Acquisition Adds Another Growth Avenue CoStar also recently completed its acquisition of Zonda, expanding further into new-home data, analytics and marketplaces. Management sees potential to combine Zonda's housing and visualization capabilities with Matterport's spatial technology. That's potentially attractive strategically, but acquisitions also create execution risk. So I don't want to assume every new asset automatically creates value. What I want to see over the next several quarters is straightforward: continued revenue growth → residential profitability → stronger consolidated margins → disciplined integration. If those occur while the stock establishes a technical bottom, the fundamental and technical stories begin reinforcing each other. Why This Setup Interests Me This is the disconnect I'm watching. Technically: distribution → high-volume breakdown → lower-volume continuation → high-volume selling near the lows → diminishing downside progress → improving momentum. Fundamentally: 18% Q2 revenue growth → rapidly improving adjusted EBITDA → residential segment reaching positive adjusted EBITDA → continued investment in long-term growth. So I'm not looking at a company where the stock fell because the underlying operation completely collapsed. The question I'm asking is: Has the stock's decline now discounted more deterioration than the operating results are actually showing? Price has to answer that. My Bullish Scenario My preferred sequence would be: $27–$32 base holds → momentum remains positive → $33–$35 reclaimed → controlled retest → higher low → $40–$45. If CSGP subsequently reclaims the declining weekly trend and establishes support above it, I'd become considerably more constructive. From there, $50–$55 would be the next meaningful recovery area, followed eventually by the prior distribution region around $60–$70. I wouldn't jump directly to those targets. I want price to build the structure first. My Bearish Scenario The bearish scenario is straightforward. If CSGP decisively loses approximately $27–$28, especially with renewed volume expansion and deteriorating momentum, I'd assume the base hasn't finished forming. That would weaken the absorption thesis considerably. I'd rather wait for another stabilization area than try to predict where the next low will occur. My Bias I'm cautiously constructive at these levels, but I don't think the reversal is confirmed yet. The combination I like is: high-volume distribution → declining selling participation → another high-volume event near the lows → limited downside follow-through → consolidation → momentum turning positive. And unlike some turnaround charts, the underlying business is still generating double-digit revenue growth while adjusted profitability has improved sharply. So for me: $27–$32 = potential accumulation zone. $33–$35 = first breakout confirmation. $40–$45 = major trend test. $50+ = stronger evidence of a larger recovery. The biggest thing I'm watching now is whether high-volume selling around the lows continues producing less and less downside. If it does—and price begins building higher lows before breaking $35—I think we'll have much stronger evidence that the long markdown is finally transitioning into a bottoming process rather than simply another pause in the decline. Trade Safely Enjoy!

TITradingView Ideas16 Sept

CSAG: Discounted Maritime Asset Retests Fib Support

📊 CSAG: Discounted Maritime Asset Retests Fib Support ⚓ 🏛️ Fundamentals: 📈 Strengths and Catalysts: FX pass-through from associate container handling terminals provides strong currency tailwinds. 💵 Annual associate dividend distribution from Port Said and Damietta terminals is expected in Q4 2026. 🚀 Strategic 20% stakes in major Mediterranean container hubs deliver recurring cash flow. 🚢 ⚠️ Weaknesses and Risks: Regional geopolitical conflicts impact Suez Canal vessel traffic and port calls. ⚠️ Thin 10% free float limits institutional position sizing. 💧 Sustained drops in Suez Canal transit volumes pose a key operational risk. 📉 🧾 Shareholders and Free Float: Holding Company for Maritime and Land Transport controls a 90.0% state stake. 🏛️ Public retail and domestic funds hold a tight 10.0% free float. 📊 🕌 Sharia Screen: Sharia status: Non-Compliant due to non-permissible interest income . ⚠️ 📈 The Pulse: YTD performance is up +12.3%. 📈 Trailing 1Y return stands at +28.5%. 📊 Stock experienced a very strong correction from its all-time high of EGP 44.45. 📉 Price has not broken the key 61.8% Fibonacci level at EGP 36.36. 🟢 P/E sits at a cheap 9.7x against sector peers at 11.2x. 🏷️ Good entry triggers when the correction stops and price closes above EGP 39.45. 📈 Fundamentally supported DCF fair value target points to EGP 48.20 if correction holds. 🎯 Stop-loss for existing holders triggers on a break below key support at EGP 34.17. 🛑 🧱 The Key Structural Boundaries • Confirmation / Entry Trigger: Daily close above EGP 39.45. 📈 • Key Fib Support: EGP 36.36. 🟢 • Hard Support / Stop-Loss: Break below EGP 34.17. 🛑 • DCF Fundamental Target: EGP 48.20. 🎯 • Strategy: Wait for a confirmed close above EGP 39.45 before entering long. 📊 🎯 Verdict: CSAG offers strong dividend potential and cheap earnings multiples backed by strategic port assets. ⚓ Correction is holding key Fibonacci support, but entry requires confirmation above EGP 39.45. 🟢 If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑

TITradingView Ideas16 Sept

XAUUSD — FOMC Breakout Buy Setup | Liquidity Sweep Continuation

Gold has been in a strong descending channel since the sharp drop from the 4,400 highs, printing lower highs and lower lows across multiple sessions. However, price has recently broken above the descending trendline resistance that capped every prior rally attempt — signaling a potential shift in short-term structure. This breakout is occurring right into a major FOMC data release, adding volatility and liquidity-driven momentum to the move. 🟢 1. BUY SIDE LIQUIDITY (~4,400+) A large pool of resting buy stops sits above the original swing high near 4,400. This untapped liquidity remains the primary draw for price — the market has a strong tendency to seek out untouched liquidity pools, and this is the most significant one on the chart. Expect price to gravitate toward this level as the bullish move develops. 🔺 2. FOMC DATA SETUP (Trendline Break) The descending trendline connecting the lower highs since the initial drop has now been decisively broken to the upside. This break of structure (BOS) is a strong signal that the corrective/bearish phase may be transitioning into a new bullish leg. Because this break coincides with FOMC, the move carries extra weight — news-driven volatility often confirms or accelerates structural shifts like this one. ⬛ 3. ORDER BLOCK (~4,280–4,300) A clean bullish order block formed near the recent swing low, right at the point where sell-side liquidity was last swept. This block represents the last point of aggressive institutional buying before the impulsive rally began — the origin of the current bullish leg and a key zone that, if retested, should hold as support. 🟫 4. STRONG FVG (~4,320–4,345) Just above the order block, a Strong Fair Value Gap formed during the impulsive push higher. This imbalance zone is currently being respected as price consolidates — the tight, choppy price action here reflects a healthy retracement/re-accumulation phase before continuation, rather than a reversal. 🔴 5. SELL SIDE LIQUIDITY (~4,260) Located at the base of the entire structure, this liquidity pool was swept during the final leg down, providing the fuel (stop-hunt) for the current bullish reversal. With this liquidity already taken, downside pressure is reduced, reinforcing the bullish bias going forward. 🎯 TRADE THESIS Price has broken the multi-day descending trendline, confirmed by a base at the Order Block and consolidation inside a Strong FVG. With sell-side liquidity already swept below and buy-side liquidity still resting above 4,400, the path of least resistance favors continuation to the upside — especially with FOMC volatility acting as the catalyst to push price into that untapped liquidity zone. 📍 Entry: 4341.00 🛑 SL: 4322.61 🎯 TP1: 4360 | TP2: 4375 | TP3: 4390 | TP4 (Final): 4403.08 https://www.tradingview.com/x/MhEaFCzo/

TITradingView Ideas16 Sept

USOIL (WTI Crude Oil): Bullish Liquidity Sweep & Demand Re-test

Following a strong bullish surge that expanded through multiple Break of Structure (BOS) levels, price swept Buy-Side Liquidity (BSL) near 106.65 before pulling back sharply to mitigate internal demand and sweep local Sell-Side Liquidity (SSL) around 102.44. Price is currently tapping into a high-confluence discount region, offering a long setup aligned with the broader institutional trend. Institutional Market Structure (SMC) Breakdown Liquidity Sweep (SSL Captured): Price aggressively raided the sell-side liquidity pool around 102.44, clearing out weak long stops and filling institutional orders into key support. Fair Value Gap (FVG) Confluence: The primary structural accumulation zone sits inside the $101.00–$102.00 imbalance block, aligning with prior structural demand. Order Flow Alignment: The higher timeframe macro structure remains firmly bullish after successive BOS markers on the expansion leg. This current move represents a deep discount retracement to target equal highs and fresh Buy-Side Liquidity. Execution Plan Trade Type: Long / Buy Limit Setup Entry Zone: $102.50 – $102.55 Stop Loss (SL): $100.66 (below the previous low & sub-101.00 liquidity sweep level) Take Profit (TP / BSL Target): $106.65 (High-timeframe Buy-Side Liquidity pool) Risk-to-Reward (R:R): ~2.17 R Fundamental Drivers Geopolitical Risk Premium: Supply disruption fears in the Middle East and physical shipping bottlenecks through key global chokepoints maintain an underlying bid under physical crude markets. Inventory Noise vs. Macro Trend: Today's temporary intraday pullback was triggered by a short-term U.S. commercial inventory build, creating a transient discount within an otherwise tight global balance. Disclaimer: Educational analysis based on Smart Money Concepts (SMC) principles. Always enforce strict risk management.

TITradingView Ideas16 Sept

Boston Scientific: Accumulation Developing?

Good Afternoon, Hope all is well. Here is my TA on Boston Scientific. What I’m Seeing Looking at Boston Scientific on the weekly chart, the dominant trend is still bearish. Price has fallen from roughly $105–$110 to $44, remains below a declining weekly trend/average, and has yet to establish a convincing sequence of higher highs and higher lows. But the behavior of the decline is changing. I've marked three significant selling events. Earlier in the decline, heavy volume produced substantial downside movement. More recently, additional selling has produced progressively less downside, while volume itself has begun to contract. At the same time, my daily momentum has turned positive for the first time since November 2025, and the weekly negative directional component has weakened relative to the broader trend-strength measure. To me, this potentially represents: aggressive markdown → diminishing selling pressure → stabilization → potential accumulation. The bottom isn't confirmed, but I think the $40–$45 region deserves attention. The Volume Progression Is the Most Interesting Part The first high-volume event occurred around $73–$75. That didn't stop the decline. Sellers remained in control and price continued significantly lower. The next major event occurred around $55–$58, again with increasing participation. Then another occurred around $45–$48. But look at the difference in price response. The earlier selling generated large declines. The later selling generated less additional downside. That's exactly the relationship I'm interested in near the end of a prolonged markdown. I'm essentially seeing: large selling effort → progressively smaller bearish result. That can indicate seller exhaustion or absorption. It doesn't prove institutional accumulation—high volume can represent aggressive two-way trading—but if subsequent price action begins producing higher lows, the absorption thesis becomes much stronger. The $40–$45 Area Is My Decision Zone This is the most important area on the chart. Price has spent several months around the low-to-mid $40s and, despite repeated selling pressure, has so far struggled to establish itself materially below this region. That's a meaningful change from earlier in the decline. Previously, support levels were temporary. Price would stabilize, bounce slightly and then continue lower. Now I'm starting to see time being spent at the lows. That's potentially how a bottom begins. So I wouldn't automatically call $40–$45 a buy zone. I'd call it my observation / potential accumulation zone. Daily Momentum Turning Positive Matters Your annotation that daily momentum has turned positive for the first time since November 2025 is particularly interesting. During most of this decline, momentum and price were aligned: price ↓ + momentum ↓ = bearish confirmation. Now that relationship is beginning to separate. Price remains near its lows, but momentum is starting to improve. That means I may be seeing a form of momentum divergence developing underneath the price action. Again, divergence doesn't guarantee reversal. But when I combine: declining selling volume + reduced downside progress + improving momentum I start becoming much more interested in the possibility that the downtrend is maturing. The Weekly Signal Is Improving Too Your weekly directional indicator observation strengthens that argument. The negative directional component crossing underneath the weekly average directional index suggests, according to the way you're using the indicator, that bearish directional pressure is no longer behaving as strongly as it was earlier in the decline. That's an important distinction. It doesn't necessarily mean buyers have taken control. It means sellers may be losing control. Those are two different stages. The transition I'm looking for is: seller exhaustion → equilibrium → buyer control. I think BSX may be somewhere between the first two. The August Rally Was Useful Information The rally from approximately $43 to $51–$52 was important even though it failed. It showed that buyers can move price when selling pressure temporarily disappears. But price couldn't sustain itself above $50 and subsequently returned toward the base. That tells me the reversal isn't mature yet. What happens on this retest matters much more than the original rally. If price now holds approximately $42–$44 and subsequently creates another push toward $50, I may have the beginnings of: low → rally → higher low → breakout. That's the structural sequence I'm waiting for. $50–$52 Is My First Major Confirmation The immediate resistance area is approximately $49–$52. That's where the August recovery failed. So I don't become significantly more bullish simply because BSX moves from $44 to $47. I want the market to prove it can remove the previous swing high. Ideally: $40–$45 base → $50–$52 breakout → controlled pullback → $46–$48 holds → continuation. That would be the first meaningful change from the persistent lower-high structure. $55–$60 Would Change the Character of the Chart Above $52, I think $55–$60 becomes the next important area. That's where one of your previous high-volume selling events occurred and where price accelerated downward. If BSX can reclaim that region, I'd start viewing the chart very differently. Instead of simply having a potential bottom, we'd potentially have: base → higher low → higher high → trend recovery. After that, the declining weekly average around the low/mid-$60s becomes the major longer-term test. So my technical roadmap is approximately: $40–$45 → $50–$52 → $55–$60 → $63–$67 weekly trend. I want each level reclaimed before assuming the next. Fundamentals — This Is Not a Broken Business This is where BSX becomes particularly interesting. Boston Scientific's Q2 2026 revenue was $5.44 billion, up 7.5% reported and 7.0% organically. GAAP EPS increased to $0.61 from $0.53, while adjusted EPS increased to $0.86 from $0.75. Cardiovascular organic sales grew 7.8%, while MedSurg grew 5.4%. So unlike some of the distressed charts we've looked at, I'm not dealing with collapsing revenue. The company is still growing. That creates an interesting disconnect: business growing → earnings growing → stock down roughly 60% from its highs. That doesn't automatically make the stock cheap—the previous valuation may simply have been too high—but it does make me much more interested in what price is doing around these lows. There Are Real Reasons for the Selloff I wouldn't dismiss the bearish case, though. Management lowered its full-year outlook after Q2. Adjusted EPS guidance fell from $3.34–$3.41 to $3.28–$3.32, while organic sales-growth guidance was reduced to 5–6%. A major reason has been weaker-than-expected demand for the Watchman heart implant, along with increased competition in the U.S. electrophysiology market. Management indicated some of the Watchman pressure could continue into 2027. So the market isn't repricing BSX for no reason. Growth expectations have come down. The question is whether the stock decline has now gone far beyond the deterioration in the underlying business. And There's a New Short-Term Risk: The Cyberattack This is important because it happened after the Q2 report. On September 8, Boston Scientific said a cybersecurity incident discovered August 25 had disrupted global operations, including manufacturing and order processing. The company said it is now unlikely to meet its previously issued Q3 and full-year 2026 sales and adjusted-profit guidance because of the disruption. Major manufacturing and distribution operations were recovering, but management couldn't yet quantify the full financial impact. That's a significant near-term uncertainty. And it may help explain why price has returned toward the lows even after the August rally. The next major fundamental catalyst is therefore the October 28 Q3 report, when management expects to provide an updated outlook. Why the Cyber Event Matters to My Technical Thesis This is actually where price behavior becomes particularly useful. BSX has just received another piece of legitimately negative news. Yet price is still sitting around $44 rather than immediately collapsing through the previous lows. I'm watching that closely. If a stock receives increasingly negative headlines but stops making meaningful new lows, that's potentially evidence that the market has already discounted substantial bad news. I wouldn't call that proof yet. But if the cyberattack's financial consequences become clearer and BSX still holds the $40–$45 area, the support becomes much more meaningful to me. The Product Pipeline Still Matters The longer-term business hasn't stopped innovating either. Boston Scientific's FARAPULSE pulsed-field ablation franchise remains an important cardiovascular growth platform. In Q2, its AVANT GUARD study met its safety and effectiveness endpoints and showed superiority over anti-arrhythmic drugs for the studied persistent atrial-fibrillation population. The company has also begun the pivotal FARADIGM trial for its FARAFLEX mapping and ablation catheter. That matters because the long-term bull case isn't simply: "the stock fell a lot." It's: the stock experienced severe multiple compression while the company continues growing and investing in important medical-device franchises. If growth stabilizes after the current operational disruptions, that could eventually provide fundamental support for the technical bottom. Why This Setup Interests Me The technical and fundamental pictures are beginning to line up in an interesting way. Technically: heavy selling → lower lows → additional selling → less downside progress → declining volume → improving momentum → potential base. Fundamentally: continued revenue growth + EPS growth + strong product franchises but also: lower guidance + Watchman weakness + EP competition + cyber disruption. That tells me this isn't a simple story. The business remains healthy enough that I don't need to bet on corporate survival. I mainly need to determine whether expectations have finally been reset low enough for price to stabilize. My Bullish Scenario My preferred sequence would be: $40–$45 holds → selling volume continues declining → daily momentum remains constructive → $50–$52 reclaimed → higher low → $55–$60 breakout. If that happens, the declining weekly trend around roughly $63–$67 becomes the major test. A successful reclaim of that weekly trend would be the point where I'd start taking a larger reversal much more seriously. Beyond there, I'd eventually watch the prior breakdown areas around $70–$75 and then $78–$80. I don't need to predict a return to $100 today. I want the market to build the staircase first. My Bearish Scenario The bearish scenario is straightforward. If BSX loses approximately $40–$42, particularly with expanding volume and renewed negative momentum, my accumulation thesis weakens considerably. I'd be especially cautious if that happened alongside a materially worse-than-expected cyberattack impact or another deterioration in underlying growth expectations. That combination would tell me: this isn't absorption yet—the market is still repricing the business. I'd rather wait for another base than guess where the next low will occur. My Bias I'm cautiously constructive around $40–$45, but I don't think the weekly reversal has been confirmed yet. What gets my attention is the combination of: Repeated selling events producing progressively less downside Volume beginning to contract near the lows Daily momentum turning positive Weekly bearish directional pressure weakening Price spending more time around $40–$45 rather than immediately breaking lower An underlying business that still generated 7% organic growth in Q2 Adjusted EPS that increased from $0.75 to $0.86 year over year But I also have to respect the cyberattack, weaker Watchman trends and reduced growth expectations. So for me: $40–$45 = potential accumulation / decision zone. $50–$52 = first structural confirmation. $55–$60 = meaningful trend improvement. $63–$67 = major weekly reversal test. The key thing I'm watching now is effort versus result. If sellers continue attacking the $40–$45 area but price refuses to move materially lower, while momentum continues improving, I'll become increasingly interested. If buyers then push BSX through $50–$52 with stronger participation, I'll have much better evidence that what currently looks like seller exhaustion is actually beginning to transition into accumulation and a new recovery cycle. Trade Safely Enjoy!

TITradingView Ideas16 Sept

AXPH: Defensive Pharma Play Retests Triangle Pattern

📊 AXPH: Defensive Pharma Play Retests Triangle Pattern with Ultra-Low Liquidity 💊 🏛️ Fundamentals: 📈 Strengths and Catalysts: FY2025/2026 net profit rose 35% year over year to EGP 528 mn on revenues above EGP 2.2 bn. 📈 Strong pricing power follows Egyptian Drug Authority price adjustments on essential medicine portfolios. 🏷️ Expanding export sales target regional MENA markets. 🌍 Balance sheet boasts a zero net debt burden with strong operational cash generation. 💵 Potential Q4 2026 price revisions on essential drugs serve as an upcoming catalyst. 🚀 High cash dividend yield combines with state backing and defensive market share. 💰 ⚠️ Weaknesses and Risks: High dependency on imported Active Pharmaceutical Ingredients exposes margins to EGP devaluation pressures. 🌐 Strict domestic retail price caps persist on essential medicine categories. ⚠️ 🧾 Shareholders and Free Float: State owned Holding Co. for Pharmaceuticals holds a controlling 60.0% stake. 🏛️ Local institutional and public funds own 18.5%. 🏢 Public market free float stands at 21.5%. 📊 🕌 Sharia Screen: Sharia status: Compliant, interest income to revenue sits at 1.8%, below the 5.0% threshold. 🟢 📈 The Pulse: YTD performance is up +48.2%. 📈 Trailing 1Y return stands at +141.7%. 📊 Primary uptrend remains intact with strong outperformance against the EGX30 index. 🚀 Price has seen minimal correction due to the high nominal cost per share. 🔍 Daily liquidity remains very low around EGP 12 mn per day. 💧 Chart is forming a triangle pattern. 📐 Breaking the upper band of the triangle opens up good upside targets. 🎯 Entry is not recommended without a triangle breakout on heavy volume. 🛑 Alternatively, wait for sideways consolidation to let indicators cool off and valuation ratios become cheaper. ⏳ Valuation looks high at 16.1x TTM P/E against the sector median of 14.9x which is already high. 📊 A volatility stop is placed at EGP 1,545.00 based on 2.5x ATR14. 🛡️ 🧱 The Key Structural Boundaries • Volatility Stop: EGP 1,545.00. 🛑 • Hard Stop-Loss: EGP 1,480.00. 🛑 • Strategy: Avoid entering until a high-volume breakout or extended sideways cooling occurs. 📊 🎯 Verdict: Thin liquidity and high per-share price limit volatility, keeping price locked inside a consolidation triangle. 📐 Holders should guard position risk while prospective buyers wait for a volume-backed breakout above resistance. ⏳ If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑

TITradingView Ideas16 Sept

GOLD H1: Bearish Rejection — Is 4317 the Gateway to 4289–4261?

The H1 chart shows a short-term bearish setup, but it does not yet confirm a straight decline toward the final downside target. Price was rejected from 4355–4365, followed by a SELL signal and a local swing high. Two consecutive bearish candles have formed, while the dashboard shows Strong Bearish, bearish confirmation, and 100% candle strength. However, the H1 structure remains broadly bullish while price holds above PDH 4317.15. A move into that level could still be only a retracement. The major supply zone is approximately 4365–4400. Important downside liquidity sits at PDM 4289.13, EQL 4275.90, PDL 4261.10, followed by sell-side liquidity around 4242.57 and 4234.52. My primary scenario: Decline toward 4317. Possible rebound into 4335–4350. If that rebound is rejected and an H1 candle closes below 4317, the next objectives become 4289 → 4276 → 4261. A confirmed break below 4261 would expose 4243–4235. The 4216 bear target is an extended objective, not a guaranteed same-day target. Bearish invalidation: an H1 recovery and close above 4357–4365. That could reopen 4383, followed by 4400. Bottom line: the projected bearish direction is technically reasonable, but the exact path is too precise to trust. 4317 is the decision level—above it, this is mainly a pullback; below it, the bearish case becomes substantially stronger. Probability over prediction. https://www.tradingview.com/x/EZhHhnvJ/

TITradingView Ideas16 Sept
TI

SNDK LONG SETUP

https://www.tradingview.com/x/TzkUZWgL/ SNDK LONG SETUP Waiting for the pullback, not chasing the rebound. Entry: $1,500 Stop Loss: $1,450 Take Profit: $1,800 Trigger: Hold the $1,450–$1,500 zone and reclaim momentum. Invalidation: Close below $1,450 → cancel the long setup and wait for a new base. Key catalyst: AI + data-center NAND demand. ⚠️ SNDK is highly volatile. For Bitget RSNDK/USDT, use percentage-based levels since the contract price may differ from the cash market. NFA. Always DYOR.

TITradingView Ideas16 Sept

TOTAL vs US Real Yields: Fed Decision Watch

Why does tonight's Fed decision matter for crypto? It isn't really about a 25 bp hike — the market has largely priced it in. The real question: what happens to US real yields and the dollar after the decision? 📊 WHERE CRYPTO STANDS (pre-decision) - Total crypto market cap: ~$2.64T (Sep 15), BTC dominance ~58%. - BTC: ~$75.7K, roughly 40% below its October 2025 all-time high. - Fear & Greed: dropped from 69 (Greed) to 51 (Neutral) in one day. - Extra headwind: the CLARITY Act failed its Senate procedural vote on Sep 15 — a major regulatory catalyst delayed. - ETF context: US spot BTC ETFs took in ~$3.5B in August, BTC's best month since Nov 2024 — but early September already saw outflows. 📊 US MACRO SNAPSHOT - Jobs: +162K in August vs 53K expected. Unemployment 4.1%. - Inflation: headline CPI 3.4%, mostly energy-driven. Core CPI 2.4%, lowest since 2021, but the monthly core print came in hot. - Retail sales (today): +1.2% vs +0.8% expected; control group +1.4% vs +0.4%. Bottom line: the economy is holding up, inflation is sticky because of oil, and the Fed is under pressure to tighten. 🔍 THE INDICATOR I'M WATCHING: DFII10 DFII10 is the 10-year US Treasury real yield — the return after expected inflation. - 2.60% (Sep 14 close), up from 2.43% a week earlier. - Nominal 10Y closed at 5.00% on Sep 15, the highest close since 2007. https://www.tradingview.com/x/1FkRtn1T/ Key point: breakeven inflation is roughly flat near 2.4%. Yields aren't rising on inflation fears — real yields themselves are climbing. Why crypto cares : BTC pays no yield. When investors can earn a 2.6% real return in a risk-free dollar asset, the opportunity cost of holding non-yielding, high-volatility assets rises. Rising real yields usually mean: - Tighter dollar liquidity. - Weaker risk appetite and slower ETF inflows. - Lower tolerance for leverage → larger liquidation cascades. - Altcoins typically take a bigger hit than BTC (higher beta). 🎯 WHAT'S PRICED IN? - Futures price ~90% odds of a 25 bp hike to 3.75%–4.00% — the first since July 2023. - Reuters poll (Sep 14): 86 of 101 economists expect a hike; 37 of 70 expect at least one more by end-March 2027. - Futures price roughly 4 hikes through July 2027. 🏦 WARSH & THE FED - July: held 9–3, three dissenters wanted a hike. - Jackson Hole: Warsh avoids advance commitments to markets, but said the Fed "has work to do" if core inflation doesn't fall fast enough. Hike odds jumped from 34% to 57% afterward. 🏛 POLITICAL PRESSURE The White House says a hike isn't necessary — that argues for a hold, not a cut. Cuts aren't in current pricing. My view: cuts could return later if the labor market weakens clearly, oil drops sharply, or 5%+ yields start breaking financing conditions. A hold tonight isn't risk-free: Deutsche Bank says it would be the biggest dovish surprise at a scheduled meeting since 1994. If read as political capitulation, long-end yields could rise anyway. 💭 WHAT COULD ACTUALLY MOVE MARKETS - Dot plot: June signaled one hike in 2026. An extra hike = a tightening cycle. - Dissents and updated projections. - The reaction in DFII10, US10Y and DXY during the press conference — crypto often trades the presser, not the headline. 🌏 DON'T IGNORE JAPAN The BoJ is expected to lift rates to a 31-year high. A stronger yen can force unwinds of yen-funded carry trades — the same mechanism behind the sharp crypto sell-off in August 2024. 🔀 POST-DECISION SCENARIOS 1️⃣ Hike 25 + DFII10 stable/falling → "sell the rumor, buy the news" relief; supportive for TOTAL. 2️⃣ Hike 25 + hawkish dots + DFII10 above 2.50% → pressure; alts likely underperform BTC. 3️⃣ Surprise hold → sharp initial pump that may fade if bonds read it as soft on inflation. 4️⃣ Hike 50 → very unlikely, clear risk-off shock and liquidation risk. ✅ WHAT TO WATCH AFTER THE DECISION - DFII10: back below 2.50%, or holding above? - US10Y: sustaining above 5%? - DXY: ~99.7 — a break above 100 is a warning sign. - BTC dominance: rising dominance = defensive rotation out of alts. - ETF flows on Thursday and Friday. Easing yields and dollar = breathing room for crypto. Holding above these levels = pressure persists. ⏰ Decision: 2:00 PM ET (18:00 UTC). Press conference: 2:30 PM ET. Data as of Sep 16, 2026, before the decision. Educational content, not investment advice.

TITradingView Ideas16 Sept

Gold next move, expecting bullish move (16-09-2026)

Plz Go through the analysis carefully and do trade accordingly. Anup 'BIAS for the day (16-09-2026) Current price- 4340 "if Price stays above 4295-4300, then next target is 4390, 4445, 4480, 4510 & 4580 if price break this Key-area 4295-4300 , then the next target will be 4250, 4220 & 4160". Advice- (analysis is valid if FED doesn't hike interest rate in FOMC release) Reasons: 1. As per Eliot wave theory, in 4H time frame, the fourth correctional wave has completing ABC correction. Now if it sustains the we will see 5th impulse wave targeting 4900. 2. in 1-Week time frame, the price already tapped imbalance now 1D,4H gave good reaction, which indicates possible bullish move. 3. in 1D time frame, the price have taken liquidity downside and it created HH low (strong low) and now it is trading near diagonal resistance (in 4-H completed 123 move ) which indicates possible bullish move. 3. in 4-H time frame price breaks the RBS zone after having made HH bottom with efficient move (123 move) and now as of publication of this analysis it is trading near diagonal resistance. it price managed to break it then we may see strong bullish move. 4. in 1-H time frame, price did MSS towards bullish direction with efficient move which indicates possible bullish move at least up to 4445 to grab upside liquidity. 5. in 15-M, 5-M it bullish structurally and moving bullish side. Best of luck, Caution: Never risk more than 1% of principal to follow any position. Support us by liking and sharing the post.

TITradingView Ideas16 Sept

USD/JPY Structure into FOMC

The BoJ rate decision may carry more potential for the USD/JPY pair on this go-round but there's some clean structure in-place ahead of the Fed meeting, where the bank is widely expected to hike for the first time in three years. The 155.00 level has so far been support all morning, and the prior swing-low turned resistance at 155.50 has been resistance. Below, it's the 153.00 level that's vital especially as we go into later-week trade with that BoJ meeting high on the calendar. If that breaches, larger fears of big picture carry unwind can compel a stronger bearish move. On the long side, carry is still positive but the bigger question is for how long trends might run. After the intervention at 164, bulls started to get more and more bold until eventually we saw the sell-off from 160.00. This can theoretically cap upside it's just that right now the only clear line-in-the-sand is 160 so the bigger question is how Bessent or the BoJ might respond to a 157 or 158, but it does feel risky going for that, at this point, and if that's clear, it can become a more widespread item as we go into some heavy event risk in the second-half of the week. - JS

TITradingView Ideas16 Sept

GBPUSD

Bullish Reversal Setup on GBP/USD: An RTM Structural Analysis ​A structural examination of the 4-hour GBP/USD chart reveals an high-probability bullish reversal setup, driven by market maker liquidity dynamics and institutional order collection based on Read The Market (RTM) concepts. ​Key Structural Drivers & RTM Rationale ​Fakeout Below Breakout Level (Liquidity Sweep): Price has descended into the critical Breakout Level (approx. 1.34189). In RTM methodology, this move represents a classic fakeout or stop-hunt designed to sweep retail liquidity and trigger sell-stop orders, providing the required fuel for a major upward displacement. ​Flag Limit Demand Zone: The highlighted Flag Limit (1.34000 – 1.34500) acts as an essential demand block. This zone contains unmitigated buy orders capable of absorbing selling pressure, holding price, and initiating a bullish reaction. ​Intermarket Confluence (DXY Weakness): The broader bullish outlook previously observed on EUR/USD provides valuable intermarket alignment. Positive correlation between major European currencies signals underlying US Dollar weakness, reinforcing the probability of a sustained rally in GBP/USD. ​Outlook & Targets ​Following the liquidity sweep beneath the breakout level and price reaction within the Flag Limit, GBP/USD is expected to launch its next impulse wave higher. ​Primary Objective (Target 1): 1.35348 ​Extended Outlook: Potential expansion toward higher liquidity pools beyond Target 1 upon solid structural confirmation.

TITradingView Ideas16 Sept
TI

ADBE bullish view

Hi everyone, Following my discussion with ExpertTrader21, I wanted to share my bullish trend continuation thesis as an alternative perspective to his bearish outlook. As I mentioned under his trade idea, I see ADBE (Adobe) as both a short-term and a long-term bullish play. 1. Short-Term Trade Setup:Risk-to-Reward (RR): I've set up a short-term 3:1 RR ratio from the current price, targeting the previous swing high.Fib Extension Target: An even higher RR can be achieved by using the Fibonacci extension to project a potential Higher High at 324.7 2. High Timeframe (HTF) Framework:Pitchfork Analysis: Some of the lines on my chart belong to a high timeframe Pitchfork. You can clearly see how the price bounced perfectly off the lower boundary of the Pitchfork and has started its mean reversion process toward the median line.HTF AVWAP: I have anchored a second AVWAP on the higher timeframe (the red line). This serves as my macro target for a long-term position in Adobe at around $400, which nicely aligns with the Pitchfork's median line. 3. Daily Chart Confluences:Market Structure: The daily chart shows a clear Market Structure Shift, now forming Higher Highs and Higher Lows.Divergences & Support: My analysis is backed by multiple volume and RSI divergences at the bottom, alongside dynamic support from the anchored VWAP where the potential new bullish vector started.Volume Profile (VPVR): The Anchored Volume Profile on the right indicates we are testing a High Volume Node, acting as strong support. If this area holds, an intermediate target before the macro move would be around $350. From a fundamental perspective, Adobe is a highly healthy company. The combination of strong business fundamentals, historically high free cash flow (FCF), and a record-low P/E ratio adds significant weight to my mean reversion thesis, signaling that the asset is deeply undervalued at current levels. Any feedback is highly appreciated! Good luck, traders!

TITradingView Ideas16 Sept